Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Massachusetts Senate Set to Correct Decades-Old Retirement Inequity for Public School Teachers
Massachusetts Senate
Legislation could benefit up to 8,500 Massachusetts educators, free up funding for cities and towns (BOSTON—6/3/2026) Massachusetts Senate leaders announced today that the Senate will take up RetirementPlus legislation to allow longtime public...
Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes
GlobeNewswire, Inc.
Clofutriben improved HbA1c and other cardiometabolic parameters in patients with Type 2 diabetes in a 6-week, placebo-controlled, randomized Phase 2 trial Subset of participants with elevated cortisol (EC) risk factors showed numerically greater...
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
GlobeNewswire, Inc.
SUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced...
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Amylyx Pharmaceuticals, Inc. – AMLX
GlobeNewswire, Inc.
BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the District of Massachusetts has approved the following announcement of a proposed class action settlement that would benefit purchasers...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
GlobeNewswire, Inc.
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved...
Scalp Health Is Becoming the Foundation of Sustainable Hair Growth: Groland Introduces an AI-Driven Molecular Solution
EIN Presswire
CHINA, June 8, 2026 /EINPresswire.com/ -- When consumers search for the best scalp serum for scalp anti-aging and hair growth, the focus is increasingly shifting beyond traditional hair-growth claims alone.
Influential Women Profiles: Jean Mineo, Executive Director of Bellforge Arts Center in Medfield, Massachusetts
EIN Presswire
MEDFIELD, MA, UNITED STATES, June 8, 2026 /EINPresswire.com/ -- Leading the Transformation of a Historic Campus into a Multidisciplinary Arts and Cultural Hub Focused on Community Engagement and Creative Access Jean Mineo is an accomplished...
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
GlobeNewswire, Inc.
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline.1 Detailed...
The Guardian Group, LLC announces Fellowship Trained and Board Certified Psychiatrist: Natasha Thrower, MD, QME
EIN Presswire
Dr. Natasha Thrower has joined The Guardian Group as a Qualified Medical Evaluator (QME) with exam locations in California in the specialty of Psychiatry.
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire, Inc.
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has entered into definitive...
The 104th Fighter Wing strengthens regional medical readiness with multi day Emergency Decontamination Course
DVIDS - Georgia
BARNES AIR NATIONAL GUARD BASE, WESTFIELD, Mass. — The Massachusetts National Guard’s 104th Fighter Wing Medical Group enhanced regional medical readiness by hosting the Air Combat Command Emergency Decontamination Course June 1–6, marking the...
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
GlobeNewswire, Inc.
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced multiple presentations at the...
DeyLight Health Foundation Launches Train-the-Trainer Nursing Program to Reduce Maternal and Newborn Deaths
EIN Presswire
Coalition of leading academic and clinical partners delivers simulation-based fellowship program in Boston hosted by Simmons University School of Nursing BOSTON, MA, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- The DeyLight Health...
Mayor Michelle Wu Highlights City’s Readiness for Summer Events and Announces Coordinated Preparation Efforts Across Boston
City of Boston
Mayor Michelle Wu joined City leaders and public safety officials at the Boston Summer Events Command Center (BSECC) to provide an update on the extensive planning and coordination efforts underway to prepare for a summer that will bring millions...
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
GlobeNewswire, Inc.
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will be presenting a corporate...
Influential Women: Healthcare operations leader Carolyn Hackett excels in global delivery & strategic problem-solving.
EIN Presswire
READING, MA, UNITED STATES, June 5, 2026 /EINPresswire.com/ -- Former NTT DATA Executive and Delta Dental Leader Recognized for Driving Healthcare Transformation Through Relationship-Based Leadership, Operational Expertise, and a Career Rooted...
Massachusetts K9 Heroes One Step Closer to Protection After Historic Senate Vote on Dakota’s Law
EIN Presswire
Massachusetts State Senate Passes Unanimously Dakota’s Law SEEKONK, MA, UNITED STATES, May 28, 2026 /EINPresswire.com/ -- The K9 PTSD Research Center proudly recognizes State Senator Kelly Dooner for her leadership in advancing Dakota’s Law, a...
Hospital Bed Solutions by Prosperity Health Releases Industry Report on Rising Aging-in-Place Demand Across New England
GlobeNewswire, Inc.
Boston, MA, May 28, 2026 (GLOBE NEWSWIRE) -- Hospital Bed Solutions by Prosperity Health released an industry report examining the growing demand for home medical equipment as aging-in-place trends continue reshaping long-term care across New...
ICE Arrests Illegal Alien Who Hospitalized Massachusetts State Trooper in Drunk-Driving Crash
U.S. Department of Homeland Security
Sanctuary politicians in Massachusetts RELEASED this illegal alien from jail after the crash WASHINGTON – The United States Department of Homeland Security (DHS) released the following statement after U.S. Immigration and Customs Enforcement (ICE)...
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs
GlobeNewswire, Inc.
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Curium™ is pleased to announce that it has prevailed in the patent dispute brought by Novartis subsidiary Advanced Accelerator Applications against Curium™ concerning Curium’s Lutetium Lu 177 dotatate...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.